Clinical Trials Logo

Clinical Trial Summary

So far, the liver has been the main target for cholesterol elimination. However, several recent studies performed in mice have described a new route of cholesterol excretion, the Trans-Intestinal Cholesterol Excretion or TICE. TICE allows direct elimination of plasma cholesterol in the feces directly via the intestine. Until now, only indirect evidence suggests that TICE is also active in humans, the goal of this proof of concept study is to provide the first proof of its existence in humans by using stable isotopes in patients with bile duct diversion.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms

  • Cholestasis
  • Occlusion of Bile Duct With an External Bile Diversion.

NCT number NCT01958216
Study type Interventional
Source Nantes University Hospital
Contact Bertrand CARIOU, Professor
Phone +33 (0)2 53 48 27 07
Email bertrand.cariou@univ-nantes.fr
Status Recruiting
Phase N/A
Start date September 2013
Completion date April 2015